These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22112537)

  • 1. Prediction of inhibitory activities of Hsp90 inhibitors.
    Swuec P; Barlow DJ
    Bioorg Med Chem; 2012 Jan; 20(1):408-14. PubMed ID: 22112537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors.
    Saxena AK; Saxena S; Chaudhaery SS
    SAR QSAR Environ Res; 2010 Jan; 21(1):1-20. PubMed ID: 20373211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inside the Hsp90 inhibitors binding mode through induced fit docking.
    Lauria A; Ippolito M; Almerico AM
    J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
    Park H; Kim YJ; Hahn JS
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6345-9. PubMed ID: 17869098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
    Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
    Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors.
    Bruncko M; Tahir SK; Song X; Chen J; Ding H; Huth JR; Jin S; Judge RA; Madar DJ; Park CH; Park CM; Petros AM; Tse C; Rosenberg SH; Elmore SW
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7503-6. PubMed ID: 21106457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity.
    Zapf CW; Bloom JD; McBean JL; Dushin RG; Nittoli T; Ingalls C; Sutherland AG; Sonye JP; Eid CN; Golas J; Liu H; Boschelli F; Hu Y; Vogan E; Levin JI
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2278-82. PubMed ID: 21420297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90.
    Buchstaller HP; Eggenweiler HM; Sirrenberg C; Grädler U; Musil D; Hoppe E; Zimmermann A; Schwartz H; März J; Bomke J; Wegener A; Wolf M
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4396-403. PubMed ID: 22632933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
    Miura T; Fukami TA; Hasegawa K; Ono N; Suda A; Shindo H; Yoon DO; Kim SJ; Na YJ; Aoki Y; Shimma N; Tsukuda T; Shiratori Y
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5778-83. PubMed ID: 21875802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design of anticancer drug leads based on three-dimensional quantitative structure-activity relationship.
    Huang XY; Shan ZJ; Zhai HL; Li LN; Zhang XY
    J Chem Inf Model; 2011 Aug; 51(8):1999-2006. PubMed ID: 21755987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new Hsp90 inhibitors by structure-based virtual screening.
    Hong TJ; Park H; Kim YJ; Jeong JH; Hahn JS
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4839-42. PubMed ID: 19560353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based identification of Hsp90 inhibitors.
    Barker JJ; Barker O; Boggio R; Chauhan V; Cheng RK; Corden V; Courtney SM; Edwards N; Falque VM; Fusar F; Gardiner M; Hamelin EM; Hesterkamp T; Ichihara O; Jones RS; Mather O; Mercurio C; Minucci S; Montalbetti CA; Müller A; Patel D; Phillips BG; Varasi M; Whittaker M; Winkler D; Yarnold CJ
    ChemMedChem; 2009 Jun; 4(6):963-6. PubMed ID: 19301319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.
    Sheikha GA; Al-Sha'er MA; Taha MO
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):603-9. PubMed ID: 21190426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying a C-terminal ATP binding sites-based novel Hsp90-Inhibitor in silico: a plausible therapeutic approach in Alzheimer's disease.
    Khalid S; Paul S
    Med Hypotheses; 2014 Jul; 83(1):39-46. PubMed ID: 24785461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening.
    Abbasi M; Sadeghi-Aliabadi H; Hassanzadeh F; Amanlou M
    J Mol Graph Model; 2015 Sep; 61():186-95. PubMed ID: 26277488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A predicted consensus structure for the N-terminal fragment of the heat shock protein HSP90 family.
    Gerloff DL; Cohen FE; Korostensky C; Turcotte M; Gonnet GH; Benner SA
    Proteins; 1997 Mar; 27(3):450-8. PubMed ID: 9094746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based discovery of a new class of Hsp90 inhibitors.
    Barril X; Brough P; Drysdale M; Hubbard RE; Massey A; Surgenor A; Wright L
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5187-91. PubMed ID: 16202589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.